Gene-Modulation Technologies in the Development of Cell-Based Therapies

Sartorius and Horizon invite you to join them for an educational webinar.

The Scientist Creative Services Team
Sep 6, 2019

Gene-Modulation Technologies in the Development of Cell-Based Therapies from thescientistllc on Vimeo.

Cell therapy, especially adoptive T-cell transfer, is an active area of cancer research and treatment. Although promising, many challenges from efficacy to safety remain.

Horizon Discovery harnesses various gene-modulation technologies, such as CRISPR, rAAV, ZFN, siRNA, and shRNA, to successfully engineer primary cells and cancer cell lines. Whole-genome pooled and targeted arrayed functional genomic screens are performed that extend to primary human T cells. Such screens could be used to identify new targets that improve CAR T-cell survival in the immunosuppressive tumor microenvironment, increase migration and infiltration, or reduce immunogenicity. Potential targets identified from these screens may be validated with follow-up in vitro or in vivo studies. In this webinar, current data from primary immune cells will illustrate how CRISPR–Cas9 and RNAi can extend the use of adoptive T-cell transfer in the clinic.

Topics to be covered:

  • Overview of gene-modulation technologies and functional genomic screens
  • Areas in which CRISPR-Cas9 and RNAi could be used to extend the use of adoptive T-cell transfer in the clinic

Meet the Speakers:

John O'Rourke, PhD
Head of Product Development, Cell Analytics

Verena Brucklacher-Waldert, PhD
Principal Scientist
Horizon Discovery Ltd.

May 2020

Making Memories

The fundamental cognitive process is revealing itself to science


Sponsored Product Updates

NanoString and OnRamp BioInformatics Partner to Develop Cloud-Based Analysis Solutions for nCounter Data
Expanded Functionality to Support COVID-19 Research Immediately Available Through Early Access 
Optimizing Live Cell Monitoring
Download this white paper to learn how to optimize live cell monitoring workflows for advanced cell models
Troubleshooting Water Problems in Laboratory Experiments
Download this guide to learn tips for cell culture, molecular biology, and liquid chromatography!
FDA Lists Bio-Rad’s CFX96 Dx Real-Time PCR System for IVD Testing
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its CFX96 Dx Real-Time PCR System has been listed with the U.S. Food and Drug Administration (FDA) for IVD testing and may be used to help in the diagnosis of COVID-19.